UBS’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$4K Buy
+1,290
New +$4K ﹤0.01% 6241
2014
Q2
Sell
-1,517
Closed -$4K 6921
2014
Q1
$4K Sell
1,517
-19,054
-93% -$50.2K ﹤0.01% 6103
2013
Q4
$57K Buy
20,571
+20,284
+7,068% +$56.2K ﹤0.01% 4442
2013
Q3
$2K Sell
287
-93
-24% -$648 ﹤0.01% 6157
2013
Q2
$3K Buy
+380
New +$3K ﹤0.01% 5923